Clin2
NCT05853627Possibly a fitRecruiting

Propranolol versus standard therapy for trauma imagery reactions

Stress Disorders, Post-Traumatic

Treatments studied

Part of Mental health clinical trials.

This study tests whether propranolol (a beta-blocker) changed alongside a standard approach can reduce how strongly your body reacts during traumatic imagery. It’s meant for adults who have had a traumatic event and may help lessen fear and stress responses tied to those memories.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You’re between 18 and 65 years old
  • You’ve had a traumatic event and have trauma symptoms on a PTSD checklist (PCL-5 score above 33)
  • During baseline testing with guided traumatic imagery, your body reactions must meet the study’s threshold
  • Your resting blood pressure is at least 90/60 and your resting heart rate is at least 50
  • You can safely take propranolol and have no past bad reaction to beta-blockers

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06215313Enrolling by invitation
Comparing two therapies for trauma memories

This study compares two types of therapy—EMDR and imagery rescripting—to help people who have upsetting memories or nightmares from past events. It's for people with depression or PTSD, and you'll need to come to therapy twice a week.

Eindhoven, North Brabant
NCT02560805Recruiting· Phase 2
Study drugs that affect stress nerves and blood pressure in PTSD

This Phase 2 study looks at how stress-related nerve activity and a hormone called angiotensin II may be involved in PTSD, and how specific blood-pressure-related medicines affect the body. You may be eligible if you are a PTSD patient (or a matched control without PTSD) and meet safety criteria.

Decatur, Georgia
NCT05788302Recruiting
Studying prolonged exposure for PTSD and how it helps

This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.

Boston, Massachusetts
NCT04985344Recruiting· Phase 3
Propranolol to treat PTSD symptoms in children using memory reactivation

This trial studies whether propranolol (a heart-related medicine) can help children with post-traumatic stress disorder (PTSD) after a special memory-activation session. The goal is to reduce PTSD symptoms compared with the comparison condition.

Toulouse
NCT07792122Not yet recruiting· Phase 3
Propranolol for post-traumatic stress in women after violence

This study tests whether a medicine called propranolol can help women who have experienced severe violence and now have post-traumatic stress disorder (PTSD). It aims to reduce symptoms by reactivating traumatic memories while taking the medicine.

Montpellier
NCT07452978Not yet recruiting· Phase 2
Propranolol to prevent post-traumatic stress disorder after sexual violence

This trial tests a medicine called propranolol (a beta-blocker, usually used for heart conditions) to see if taking it soon after a sexual assault can help prevent the development of PTSD. It is for women who come to a medical-legal unit within 72 hours of the assault.

Hear when a new Stress Disorders, Post-Traumatic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.